SCHEMBL8232160

SCHEMBL8232160

CC(C)(c1ccccc1)N1CCC(N)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 1/20 0.61
CHRM3 P20309 8/20 0.43
CHRM2 P08172 6/20 0.43
CHRM1 P11229 3/20 0.43
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
OPRM1 P35372 1/20 0.37
GRIN1 Q05586 1/20 0.37
KCNH2 Q12809 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
OPRL1 P41146 1/20 0.36
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36
SKP2 Q13309 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19614353 0.81 CYP2B6 (0.61) CYP2B6CHRM3CHRM2ATML3MBTL1
SCHEMBL3760488 0.81 CHRM3 (0.45) CYP2B6CHRM3CHRM2CHRM1OPRL1
SCHEMBL28067245 0.78 CYP19A1 (0.43) CYP2B6
SCHEMBL30364035 0.78 CYP2B6 (0.88) CYP2B6CHRM3CHRM2CHRM1GRIN2D
SCHEMBL19011533 0.78 CYP2B6 (0.96) CYP2B6CHRM3CHRM2CHRM1GRIN2D
SCHEMBL17513237 0.78 CHRM2 (0.43) CYP2B6CHRM3CHRM2CHRM1KCNH2
SCHEMBL11398380 0.76 CYP2B6 (1.00) CYP2B6CHRM3CHRM2CHRM1OPRM1
SCHEMBL2697745 0.76 CYP2B6 (1.00) CYP2B6CHRM3CHRM2CHRM1OPRM1
SCHEMBL25533428 0.76 CYP2B6 (0.70) CYP2B6CHRM2CHRM1GRIN2DGRIN3B
Tert-Butylbenzene SCHEMBL26616626 0.76 TAAR1 (0.43) CHRM3CHRM2CHRM1OPRL1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007106525-A1 PIPERIDINYL, INDOLYL, PIRINIDYL, MORPHOLINYL AND BENZIMIDAZOLYL UREA DERIVATIVES AS INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE FOR THE TREATMENT OF HYPERTENSION, INFLAMMATIONS AND OTHER DISEASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-09-20 WO disclosed